BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

13 articles for D Thompson

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis and Pharmacological Characterization of Novel Glucagon-like Peptide-2 (GLP-2) Analogues with Low Systemic Clearance.EBI
Ferring Research Institute
New, potent, and selective peptidic oxytocin receptor agonists.EBI
Ferring Research Institute
Noreupenifeldin, a tropolone from an unidentified ascomycete.EBI
Merck Research Laboratories
Development of a bivalent dopamine D2 receptor agonist.EBI
Friedrich-Alexander University
Highly potent 5-aminotetrahydropyrazolopyridines: enantioselective dopamine D3 receptor binding, functional selectivity, and analysis of receptor-ligand interactions.EBI
Friedrich-Alexander University
Synthesis and biological activity of anticoccidial agents: 2,3-diarylindoles.EBI
Scynexis
Synthesis and biological activity of imidazopyridine anticoccidial agents: Part II.EBI
Scynexis
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition.EBI
Cold Spring Harbor Laboratory
Synthesis and biological activity of imidazopyridine anticoccidial agents: part I.EBI
Scynexis
Synthesis and SAR studies of very potent imidazopyridine antiprotozoal agents.EBI
Merck Research Laboratories
Synthesis and SAR of 2,3-diarylpyrrole inhibitors of parasite cGMP-dependent protein kinase as novel anticoccidial agents.EBI
Merck Research Laboratories
Design and synthesis of new templates derived from pyrrolopyrimidine as selective multidrug-resistance-associated protein inhibitors in multidrug resistance.EBI
Xenova
Studies on pyrrolopyrimidines as selective inhibitors of multidrug-resistance-associated protein in multidrug resistance.EBI
Xenova